Xoma reported $0 in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agenus AGEN:US $ 14.18M 0.63M
Agios Pharmaceuticals AGIO:US $ 1.22M 0.7M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Celldex Therapeutics CLDX:US $ 0M 0M
Chimerix CMRX:US $ 0M 14M
Curis CRIS:US $ 0M 0M
Eli Lilly And LLY:US $ 16813.8M 305M
Epizyme EPZM:US $ 232.49M 0.38M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Life Technologies LIFE:US $ 0M 0M
Macrogenics MGNX:US $ 0M 0M
Novartis NVS:US $ 31031M 244M
Novartis NOVN:VX SF 31031M 244M
Prothena PRTA:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Teva Pharmaceutical Industries TEVA:US $ 22082M 835M
Xoma XOMA:US $ 0 0
YTE INCY:US $ 34.19M 0.01M